Eli Lilly Canada Inc. & al v. Novopharm Limited, 2012 FCA 232 (Olanzapine*)

Justice Nadon; Justice Sharlow; Justice Trudel - 2012-09-10

Read full decision. Automatically generated summary:

Despite the able submissions of counsel for the appellant, we have not been persuaded that the judgment under appeal is based on any error of law or principle or any palpable and overriding error of fact.

Decision relates to:


Canadian Intellectual Property